These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 28946564)

  • 21. Aberrant hypermethylation of RASSF2 in tumors and peripheral blood DNA as a biomarker for malignant progression and poor prognosis of esophageal squamous cell carcinoma.
    Guo W; Dong Z; Cui J; Guo Y; Shen S; Guo X; Kuang G
    Clin Exp Metastasis; 2016 Jan; 33(1):73-85. PubMed ID: 26482475
    [TBL] [Abstract][Full Text] [Related]  

  • 22. SMYD3 stimulates EZR and LOXL2 transcription to enhance proliferation, migration, and invasion in esophageal squamous cell carcinoma.
    Zhu Y; Zhu MX; Zhang XD; Xu XE; Wu ZY; Liao LD; Li LY; Xie YM; Wu JY; Zou HY; Xie JJ; Li EM; Xu LY
    Hum Pathol; 2016 Jun; 52():153-63. PubMed ID: 26980013
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Positive transforming growth factor-β activated kinase-1 expression has an unfavorable impact on survival in T3N1-3M0 esophageal squamous cell carcinomas.
    Wen J; Hu Y; Luo KJ; Yang H; Zhang SS; Fu JH
    Ann Thorac Surg; 2013 Jan; 95(1):285-90. PubMed ID: 23272845
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prognostic significance of programmed death-1 and programmed death-ligand 1 expression in patients with esophageal squamous cell carcinoma.
    Chen K; Cheng G; Zhang F; Zhang N; Li D; Jin J; Wu J; Ying L; Mao W; Su D
    Oncotarget; 2016 May; 7(21):30772-80. PubMed ID: 27120796
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Tyrosine-protein phosphatase nonreceptor type 12 is a novel prognostic biomarker for esophageal squamous cell carcinoma.
    Cao X; Li Y; Luo RZ; He LR; Yang J; Zeng MS; Wen ZS
    Ann Thorac Surg; 2012 May; 93(5):1674-80. PubMed ID: 22429674
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Expression and significance of vascular endothelial growth factor C from multiple specimen sources in esophageal squamous cell carcinoma.
    Zhang W; Zhang M; Zhou B; Jia Z; Qiao Z; Zhang J
    Int J Biol Markers; 2012 Dec; 27(4):e359-65. PubMed ID: 23125006
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Phosphorylated mammalian target of rapamycin expression is associated with the response to chemoradiotherapy in patients with esophageal squamous cell carcinoma.
    Li SH; Huang EY; Lu HI; Huang WT; Yen CC; Huang WC; Chen CH
    J Thorac Cardiovasc Surg; 2012 Dec; 144(6):1352-9, 1359.e1. PubMed ID: 22841170
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The role of mitochondrial folate enzyme MTHFD1L in esophageal squamous cell carcinoma.
    Yang YS; Yuan Y; Hu WP; Shang QX; Chen LQ
    Scand J Gastroenterol; 2018 May; 53(5):533-540. PubMed ID: 29171320
    [TBL] [Abstract][Full Text] [Related]  

  • 29. RNF113A promotes the proliferation, migration and invasion, and is associated with a poor prognosis of esophageal squamous cell carcinoma.
    Wang L; Hou Z; Hasim A; Abuduerheman A; Zhang H; Niyaz M; Awut I; Upur H; Sheyhidin I
    Int J Oncol; 2018 Mar; 52(3):861-871. PubMed ID: 29393393
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Upregulation of PDK1 associates with poor prognosis in esophageal squamous cell carcinoma with facilitating tumorigenicity in vitro.
    Yang Z; Wu Z; Liu T; Han L; Wang C; Yang B; Zheng F
    Med Oncol; 2014 Dec; 31(12):337. PubMed ID: 25416048
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Overexpression of Phosphoserine Aminotransferase 1 (PSAT1) Predicts Poor Prognosis and Associates with Tumor Progression in Human Esophageal Squamous Cell Carcinoma.
    Liu B; Jia Y; Cao Y; Wu S; Jiang H; Sun X; Ma J; Yin X; Mao A; Shang M
    Cell Physiol Biochem; 2016; 39(1):395-406. PubMed ID: 27372650
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Association of p53 expression with prognosis in patients with esophageal squamous cell carcinoma.
    Yao W; Qin X; Qi B; Lu J; Guo L; Liu F; Liu S; Zhao B
    Int J Clin Exp Pathol; 2014; 7(10):7158-63. PubMed ID: 25400812
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Loss of CRNN expression is associated with advanced tumor stage and poor survival in patients with esophageal squamous cell carcinoma.
    Hsu PK; Kao HL; Chen HY; Yen CC; Wu YC; Hsu WH; Chou TY
    J Thorac Cardiovasc Surg; 2014 May; 147(5):1612-1618.e4. PubMed ID: 24263008
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Methylation of the promoter of human leukocyte antigen class I in human esophageal squamous cell carcinoma and its histopathological characteristics.
    Qifeng S; Bo C; Xingtao J; Chuanliang P; Xiaogang Z
    J Thorac Cardiovasc Surg; 2011 Mar; 141(3):808-14. PubMed ID: 21335133
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Increased intraepithelial CD3+ T-lymphocytes and high PD-L1 expression on tumor cells are associated with a favorable prognosis in esophageal squamous cell carcinoma and allow prognostic immunogenic subgrouping.
    Jesinghaus M; Steiger K; Slotta-Huspenina J; Drecoll E; Pfarr N; Meyer P; Konukiewitz B; Bettstetter M; Wieczorek K; Ott K; Feith M; Langer R; Weichert W; Specht K; Boxberg M
    Oncotarget; 2017 Jul; 8(29):46756-46768. PubMed ID: 28657901
    [TBL] [Abstract][Full Text] [Related]  

  • 36. ERK expression and its correlation with STAT1 in esophageal squamous cell carcinoma.
    Wang H; Zhang Y; Yun H; Chen S; Chen Y; Liu Z
    Oncotarget; 2017 Jul; 8(28):45249-45258. PubMed ID: 28431406
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prognostic significance of tumor-infiltrating immune cells and PD-L1 expression in esophageal squamous cell carcinoma.
    Jiang Y; Lo AWI; Wong A; Chen W; Wang Y; Lin L; Xu J
    Oncotarget; 2017 May; 8(18):30175-30189. PubMed ID: 28404915
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prognostic significance of gamma-glutamyltransferase in patients with resectable esophageal squamous cell carcinoma.
    Yang F; Zhang S; Yang H; Luo K; Wen J; Hu Y; Hu R; Huang Q; Chen J; Fu J
    Dis Esophagus; 2015 Jul; 28(5):496-504. PubMed ID: 24766310
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Topo2A as a prognostic biomarker for patients with resectable esophageal squamous cell carcinomas.
    Xu XL; Zheng WH; Fu ZX; Li ZP; Xie HX; Li XX; Jiang LH; Wang Y; Zhu SM; Mao WM
    Med Oncol; 2015 Jan; 32(1):396. PubMed ID: 25432700
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Do tumor location and grade affect survival in pT2N0M0 esophageal squamous cell carcinoma?
    Situ D; Wang J; Lin P; Long H; Zhang L; Rong T; Ma G
    J Thorac Cardiovasc Surg; 2013 Jul; 146(1):45-51. PubMed ID: 23490249
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.